These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6344748)

  • 1. Synergism between iron chelators and complement for bactericidal activity.
    Rivier D; Page N; Isliker H
    Ann Immunol (Paris); 1983; 134C(1):25-30. PubMed ID: 6344748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of iron and phagocytosis on murine macrophage activation in vitro.
    Gauthier YP; Isoard P
    Biol Trace Elem Res; 1995; 47(1-3):37-50. PubMed ID: 7779572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ferric and ferrous iron chelators on growth of Bacteroides fragilis under anaerobic conditions.
    Rocha ER; de Uzeda M; Brock JH
    FEMS Microbiol Lett; 1991 Nov; 68(1):45-50. PubMed ID: 1769555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ferrous and ferric chelators on transferrin-iron-macrophage interactions.
    Baynes RD; Friedman BM; Bukofzer GT; Bothwell TH; Macfarlane BJ; Lamparelli RD
    Am J Hematol; 1988 Sep; 29(1):27-32. PubMed ID: 3177366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron chelators reduce chromosomal breaks in ataxia-telangiectasia cells.
    Shackelford RE; Fu Y; Manuszak RP; Brooks TC; Sequeira AP; Wang S; Lowery-Nordberg M; Chen A
    DNA Repair (Amst); 2006 Nov; 5(11):1327-36. PubMed ID: 16959548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of iron binding agents on Saccharomyces cerevisiae growth and cytochrome P450 content.
    Wright GD; Honek JF
    Can J Microbiol; 1989 Oct; 35(10):945-50. PubMed ID: 2531030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of iron and transferrin on the killing of Escherichia coli in fresh serum.
    Fletcher J
    Immunology; 1971 Apr; 20(4):493-500. PubMed ID: 4994865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
    Jiang XP; Wang F; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2002; 22(5):2685-92. PubMed ID: 12529982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.
    Tsafack A; Loyevsky M; Ponka P; Cabantchik ZI
    J Lab Clin Med; 1996 Jun; 127(6):574-82. PubMed ID: 8648262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of iron and iron chelators on the in-vitro block to development of the mouse preimplantation embryo: BAT6 a new medium for improved culture of mouse embryos in vitro.
    Nasr-Esfahani M; Johnson MH; Aitken RJ
    Hum Reprod; 1990 Nov; 5(8):997-1003. PubMed ID: 2127939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
    Parkes JG; Randell EW; Olivieri NF; Templeton DM
    Biochim Biophys Acta; 1995 Apr; 1243(3):373-80. PubMed ID: 7727512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin.
    Hoke EM; Maylock CA; Shacter E
    Free Radic Biol Med; 2005 Aug; 39(3):403-11. PubMed ID: 15993339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of deferoxamine methanesulfonate on Trichophyton mentagrophytes.
    Kerbs S; Hutton R; Lancaster M
    Sabouraudia; 1979 Sep; 17(3):241-50. PubMed ID: 43597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron, desferrioxamine, and ATP interactions in proliferating lymphocytes and B-cell lines.
    Latunde-Dada GO; Young SP
    Biochem Soc Trans; 1995 May; 23(2):213S. PubMed ID: 7672233
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies on the susceptibility of Serratia marcescens to the bactericidal activity of human serum. Resistance of isolates against serum transferrin-mediated iron deprivation and chelation of cations by EDTA.
    Traub WH
    Exp Cell Biol; 1977; 45(3-4):184-206. PubMed ID: 409627
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of iron chelators in growth-promoting effect on mouse hybridoma cells in a chemically defined medium.
    Yabe N; Kato M; Matsuya Y; Yamane I; Iizuka M; Takayoshi H; Suzuki K
    In Vitro Cell Dev Biol; 1987 Dec; 23(12):815-20. PubMed ID: 3693250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical-promoting "free" iron level in the serum of rats treated with ferric nitrilotriacetate: comparison with other iron chelate complexes.
    Liu M; Okada S; Kawabata T
    Acta Med Okayama; 1991 Dec; 45(6):401-8. PubMed ID: 1781297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition, storage and release of iron by cultured human hepatoma cells.
    Hirsh M; Konijn AM; Iancu TC
    J Hepatol; 2002 Jan; 36(1):30-8. PubMed ID: 11804661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle effects of iron depletion on T-47D human breast cancer cells.
    Reddel RR; Hedley DW; Sutherland RL
    Exp Cell Res; 1985 Dec; 161(2):277-84. PubMed ID: 2998833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activity of M14659 enhanced in low-iron environments.
    Mochizuki H; Yamada H; Oikawa Y; Murakami K; Ishiguro J; Kosuzume H; Aizawa N; Mochida E
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1648-54. PubMed ID: 2978112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.